The Move2Treat consortium was proud to be represented at EMBC2025 through the excellent contributions and organization of Prof. Thomas Stieglitz, a member of our consortium and the Laboratory for Biomedical Microtechnology of The University of Freiburg.🔬
His mini-symposium on fibre-based neural implants directly showcased research from the Move2Treat project, highlighting our efforts toward non-invasive, personalised therapies.
We were also pleased that PhD student Emilija Bostogaite, a fellow consortium member, attended EMBC and contributed to the broader exchange of ideas around neural technologies.
These contributions reflect the innovation and collaboration at the heart of Move2Treat.
đź“Ť Follow our progress at https://move2treat.org/ and subscribe to our newsletter: https://lnkd.in/d3dhcxAd to stay updated.
